Vanguard Capital Management
MRNA icon

Vanguard Capital Management’s Moderna MRNA Stock Holding History

Vanguard Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.63B Buy
23,208,792
+336,334
+1% +$17.4M 0.03% 380
2026
Q1 		$1.16B Buy
+22,872,458
New +$1.07B 0.03% 439

Other funds holding MRNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Capital Management's MRNA Position: Q2 2026 in Review

Vanguard Capital Management increased its Moderna (MRNA) stake by 1.5% in Q2 2026, buying an estimated $17.4M and bringing the position to 23,208,792 shares worth $1.63B. The position accounts for 0.03% of the portfolio, ranked #380.

Vanguard Capital Management first reported a position in MRNA in Q1 2026 and has held it in 2 quarters since. 730 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Vanguard Capital Management held 23,208,792 shares of Moderna worth $1.63B as of Q2 2026.
  • Vanguard Capital Management bought 336,334 Moderna shares in Q2 2026, an estimated $17.4M.
  • Moderna made up 0.03% of Vanguard Capital Management's portfolio in Q2 2026, its #380 holding.
  • Vanguard Capital Management first reported a position in Moderna in Q1 2026 and has held it in 2 quarters since.
  • 730 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.